MedTrace Logo

PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk

NCT01879189 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1302

Last updated 2018-11-29

No results posted yet for this study

Summary

In order to better communicate personal risk of breast cancer to women who have not yet initiated breast cancer screening (mammography), The Annenberg School of Communication at the University of Pennsylvania has created a personal breast cancer screening decision aid tool. This tool will be pilot tested, and then implemented and tested in nine primary care and OB/GYN practices within the University of Pennsylvania Health System.

Conditions

Interventions

BEHAVIORAL

Breast Cancer Screening Decision Aid

The intervention will include access to the personal decision aid tool for patients in the intervention arm of the study, determined by the randomized physician schedule and the patient's appointment time.

Sponsors & Collaborators

Principal Investigators

  • Marilyn Schapira, MD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
39 Years
Max Age
48 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2017-04-30
Completion
2017-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01879189 on ClinicalTrials.gov